MTM Investment Management’s CVS Health CVS Stock Holding History

MTM Investment Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$928K	Sell	8,969 -516	-5%	-$46.1K	0.26%	95
2026 Q1	$681K	Hold	9,485	–	–	0.22%	103
2025 Q4	$753K	Sell	9,485 -56	-0.6%	-$4.42K	0.24%	96
2025 Q3	$719K	Hold	9,541	–	–	0.23%	101
2025 Q2	$658K	Hold	9,541	–	–	0.22%	101
2025 Q1	$649K	Hold	9,541	–	–	0.25%	99
2024 Q4	$428K	Sell	9,541 -299	-3%	-$16.8K	0.16%	127
2024 Q3	$636K	Sell	9,840 -579	-6%	-$33.8K	0.25%	91
2024 Q2	$615K	Sell	10,419 -20	-0.2%	-$1.25K	0.25%	93
2024 Q1	$833K	Sell	10,439 -149	-1%	-$11.4K	0.34%	77
2023 Q4	$836K	Hold	10,588	–	–	0.38%	71
2023 Q3	$739K	Hold	10,588	–	–	0.37%	73
2023 Q2	$732K	Buy	10,588 +1	+0%	+$71	0.36%	77
2023 Q1	$787K	Sell	10,587 -1,000	-9%	-$83.9K	0.4%	71
2022 Q4	$1.08M	Buy	11,587 +1	+0%	+$96	0.56%	54
2022 Q3	$1.1M	Sell	11,586 -147	-1%	-$14.6K	0.63%	46
2022 Q2	$1.1M	Buy	+11,733	New	+$1.15M	0.6%	50

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

MTM Investment Management's CVS Position: Q2 2026 in Review

MTM Investment Management reduced its CVS Health (CVS) stake by 5.4% in Q2 2026, selling an estimated $46.1K and leaving 8,969 shares worth $928K. The position accounts for 0.26% of the portfolio, ranked #95.

MTM Investment Management first reported a position in CVS in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.1M in Q3 2022. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

MTM Investment Management held 8,969 shares of CVS Health worth $928K as of Q2 2026.
MTM Investment Management sold 516 CVS Health shares in Q2 2026, an estimated $46.1K.
CVS Health made up 0.26% of MTM Investment Management's portfolio in Q2 2026, its #95 holding.
MTM Investment Management first reported a position in CVS Health in Q2 2022 and has held it in 17 quarters since.
MTM Investment Management's CVS Health position peaked at $1.1M in Q3 2022.
2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on MTM Investment Management's 13F filing for Q2 2026, filed 3 Aug 2026.